FDA Investigator Merideth K Rose
Merideth K Rose has inspections in 3 countries as of 07 Sep 2023. Merideth K Rose has collaborated with a combined 3501 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
39
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Spain,
Italy
Co-Investigator(s):
Adams,
Alicia M Mozzachio,
Amanda B Athey,
Amy C Amaro,
Ana P Barido,
Andrea Lwilliams Jones,
Andrew J Howard,
Annet R Rajan,
Anthony F Lorenzo,
Anthony W Lee,
Ariel Cruz Figueroa,
Ashley M Whitehurst,
Austin B Appler,
Azza Talaat,
Barbara A Burke,
Barbara A Gullick,
Brandon L Mariner,
Brandy N Lepage,
Brooke K Higgins,
Brooke K Secman,
Brooke K Seeman,
Bruce C Kovak,
Candice C Mandera,
Candice J Cortes,
Carole L Jones,
Chaltu N Wakijra,
Cheryl A Clausen,
Christine W Twohy,
Christopher R Richardson,
Chryste D Best,
Clarice J Ahn,
Colleen F Hoyt,
Cynthia A Harris, MD, RN,
Daniel T Lee,
Danielle S Pearson,
David J Gallant,
David P Rice,
Deanne E Knapp,
Decima L Washington,
Denis Mackey,
Derek S Smith, PhD,
Deshonna L Mitchell,
Diane T Bargo,
Diane T O'bien,
Diane T O'brien,
Donald L Lech,
Douglas A Campbell,
Dr. Deanne Knapp,
Dr. Sriram Subramaniam, PhD,
Edward P Potter,
Edwin Melendez,
Elvis D Morton,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Ephrem Hunde, PhD,
Eric L Dong, BS,
Eric L Vangraafeiland,
Eric M Mueller, PharmD,
Erin L Mcfiren,
Esaw,
Felix Maldonado,
Gabrielle J Swain,
Gail L Katz,
Gale L Glinecki,
George Pyramides,
Gerald B Seaborn, Jr,
Hector J Colon Torres,
Holly S Simms,
Hongna Wang,
Jacob M Dyer,
Jacqueline Johnson,
James M Simpson,
James T Mccoy,
James W Leonette,
Jamie D Swann,
Janet A Rajan,
Janete F Guardia,
Jean Blackston Hill,
Jeanne D Shaffer,
Jesse P Hardin,
Jessica D Nanini,
Jessica Hankins, PhD,
John Dan,
Johnson,
Jonathan W Chapman,
Jose R Hernandez,
Joseph A Morkunas,
Joseph W Matthews,
Jude C Dikes,
Juliana M Badalucco,
Julie A Silberberg,
Julie M Anbarchian,
Justin A Hefferman,
Justin C Fuller,
Justin H Price,
Karen A Spencer,
Kathleen M Jordan,
Keith M Reilly,
Kelly L Anderson,
Kenneth H Williams,
Kenneth M Gordon,
Kenneth Nieves,
Krista N Flores,
Lakisha M Williams,
Laurissa S Flowers,
LCDR Anastasia Mpiliafas Brown,
LCDR Cornelius Brown, III,
LCDR Debra Emerson,
Lindsey L Kirsh,
Lisa M Bellows,
Lori A Holmquist,
Lori A Holquist,
Lori S Lawless,
Lucilla Facchin,
Lynette P Salisbury,
Malgorzata G Norton,
Marc S Neubauer,
Marcellinus D Dordunoo,
Marcus A Ray,
Marion Michaelis,
Marion W Nadeau,
Marybet Lopez,
Matthew M Henciak,
Matthew R Mcnew,
Melissa J Garcia,
Michael A Taylor,
Michael J Vardon,
Miguel A Martinez,
Mildred L Mccray,
Milva E Melendez,
Mindy M Chou,
Mohamad A Chahine,
Monique Rac Lester,
Mra Davism,
Natasha A Dezinna,
Nebil A Oumer,
Nerizza B Guerin,
Nicholas A Violand,
Nicole E Knowlton,
Nicole K Trudel,
Norman Fogg,
Olaide Akinmade,
Osama M Hamoud,
Paraluman S Leonin,
Patricia A Morrow,
Patrick C Klotzbuecher,
Paula J Bretz,
Pelekakis,
Philip W Beck,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Qin Xu,
Quyen T Tran,
Rachel C Harrington,
Rafael E Arroyo,
Rebecca Rodriguez,
Regina Gibson Melton,
Robert J Martin,
Roseline N Boateng,
Sean R Moynihan, MPH,
Sena G Dissmeyer,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Stacey A Priest,
State Agency,
Stephanie L Shapley,
Steven P Donald,
Suzanne M Healy,
Suzanne M Muchene,
Suzanne Suzanne,
Tajah L Blackburn,
Tamal K Chakraborti, PhD,
Tamara N Champion,
Tamika E Allen, RN,
Teresa I Navas,
Teresa L Fox,
Theresa M Smedley,
Thomas,
Tiffani D Wilson,
Toyin B Oladimeji,
Valeria A Moore,
Valerie G Vallely,
Vesna V Stanoyevitch,
Vipulchandr N Dholakia,
Walter Fava,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
William A Warnick,
William D Murray,
William H Linkroum,
William J Leonard,
Yumi J Hiramine,
Yvonne C Mcknight,
Zakaria I Ganiyu
Merideth K Rose's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2009 | FDA 483 | Suco Inc - Form 483, 2009-05-21 |
August, 2008 | EIR | Actavis Mid-Atlantic, LLC. - EIR, 2008-08-28 |
March, 2009 | FDA 483 | Bell-More Labs Inc - Form 483, 2009-03-17 |
July, 2012 | FDA 483 | Esteve Quimica, S.A. - Form 483, 2012-07-27 |
July, 2009 | FDA 483 | CSA Medical Inc. - Form 483, 2009-07-09 |
January, 2011 | FDA 483 | Aphena Pharma Solutions - Maryland, LLC - Form 483, 2010-12-22 |
February, 2011 | FDA 483 | 3CPM Company Inc - Form 483, 2011-02-25 |
August, 2010 | FDA 483 | Cangene BioPharma, LLC - Form 483, 2010-08-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more